Change - Announcement of Cessation::Resignation of Group Financial Controller and Company Secretary

Issuer & Securities

Issuer/ Manager
AJJ MEDTECH HOLDINGS LIMITED
Securities
AJJ MEDTECH HOLDINGS LIMITED - SG0584008601 - 584
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
08-Apr-2026 21:01:26
Status
New
Announcement Sub Title
Resignation of Group Financial Controller and Company Secretary
Announcement Reference
SG260408OTHR1GDP
Submitted By (Co./ Ind. Name)
Zhao Xin
Designation
Chief Executive Officer and Executive Director
Description (Please provide a detailed description of the event in the box below)
Resignation of Mr. Tan Kee Hong ("Mr. Tan") as Group Financial Controller and Company Secretary.

This announcement has been reviewed by the Company's sponsor, Evolve Capital Advisory Private Limited ("Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST"), and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr. Jerry Chua (Tel: (65) 6241 6626) at 160 Robinson Road, #20-01/02, SBF Center, Singapore 068914.

Additional Details

Name of person
Tan Kee Hong
Age
34
Is effective date of cessation known?
Yes
If yes, please provide the date.
30/06/2026
Detailed reason(s) for cessation
Mr. Tan was appointed as Group Financial Controller and Company Secretary of the Company on 9 September 2025. Mr. Tan has tendered his resignation letter as Group Financial Controller and Company Secretary of the Company to pursue his personal interest.

Mr. Tan is currently serving the requisite notice period and his last day of employment will be 30 June 2026. The Company is in the midst of identifying a suitable qualified candidate to replace Mr. Tan and will make the necessary announcement(s) in due course.

The Company's Sponsor, after having interviewed with Mr. Tan is satisfied that, save as disclosed in the announcement, there are no material reasons for his resignation.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of appointment to current position
09/09/2025
Job title (e.g. Lead ID, AC Chairman, AC Member etc.)
Group Financial Controller and Company Secretary
Role and responsibilities
- Report directly to the CEO, Audit Committee and Board of Directors on financial compliance, governance, and statutory reporting matters, ensuring timely updates and full transparency.
- Ensure full compliance with SGX regulations, statutory financial reporting, corporate governance standards, and internal control frameworks.
- Lead the preparation and review of statutory reports, annual/quarterly/half-yearly financial statements, sustainability reports, and AGM/Board papers.
- Act as the primary liaison with regulators, auditors, financial institutions, and other relevant external stakeholders.
- Provide financial analysis, budgeting, and forecasting to support strategic and operational decision-making.
- Oversee day-to-day financial operations, including cash flow, collections, payroll, and administrative controls.
- Drive continuous improvement of financial systems, reporting processes, and efficiency measures.
- Lead and mentor the finance team, ensuring professional development and accountability.
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of independent directors currently resident in Singapore (taking into account this cessation)
3
Do independent directors make up at least one-third of the board (taking into account this cessation)?
Yes
Number of cessations of appointments specified in Mainboard Rule 704(7) or Catalist Rule 704(6) over the past 12 months
2
Shareholding interest in the listed issuer and its subsidiaries
Yes
Shareholding details
500,000 ordinary shares held in AJJ Medtech Holdings Limited
Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries
NIL
Other Directorships
Past (for the last 5 years)
NIL
Present
NIL